Machine learning, used to design proteins with a variety of functions, is doing things scientists didn't realize it was capable of.
While Omicron variants ratchet up immune evasion, study suggests current boosters intensify protections against serious infection
SKbioscience’s SKYCovione vaccine becomes the first therapeutic OK'd for people to emerge from the Institute for Protein Design.
UW Medicine’s contribution to finishing the sequence covered highly repetitive regions, include those related to human evolution.
Discovery that Lamin B1 mutation causes odd-shaped nuclei may lead to improved leukemia care.
A new method for generating potent, specific binding proteins yields candidate medicines for cancer, diabetes, inflammation and more.
Technique allows researchers to toggle on individual genes that regulate cell growth, development and function.
Map details the changes in gene activity that occur as the embryo develops and differentiates into different cell types.
A distinct immune response is observed in people who had COVID-19 and then got vaccinated.
Study findings underscore imperative of expanding test access and lowering costs.
Cryoelectron microscopy studies of Nipah and Hendra viruses may lead to ideas for vaccine design and antibody treatments.
Findings explain how mutations allow the omicron variant to evade antibodies against previous variants yet remain so infectious.
People vaccinated three times or vaccinated after an earlier COVID-19 infection had comparable neutralizing antibody activity to those with a breakthrough case.
The antibody closely mimics the binding site that the SARS-CoV-2 virus uses to infect cells, and seemingly thwarts invasion via mutation.
A genomic study of a sustained, multidrug-resistant Shigellosis outbreak in Seattle enabled scientists to retrace its origin and spread.